Medical Risk Is Never Shared Equally. Our Health Care System Is Built to Guarantee That.
When the Johnson & Johnson Covid-19 vaccine was temporarily paused after six people got blood clots postvaccination, one line of response was frustration that six out of around seven million people could prompt what seemed an extreme intervention. The Food and Drug Administration emphasized that the measure was taken in part because administering a typical treatment for blood clots had adverse effects with the six cases seen postvaccine—a type of clot called cerebral venous sinus thrombosis—and... Читать дальше...